Subscribe
Sign in
Subscribe
Sign in
GlobalData
GlobalData

Business Fundamentals

Biopharma venture financing declines 20.2% YoY in Q1 2025 amid persistent investor caution, reveals GlobalData

Biopharmaceutical drug company venture financing witnessed a year-on-year (YoY) 20.2% downturn from $8.1 billion during the first quarter (Q1) of 2024 to $6.5 billion in Q1 2025. This suggests that the biopharmaceutical venture financing environment remains challenging, mirroring a similar downturn seen in 2022 and 2023, with investors continuing to favor later-stage companies with clinical […]
Read more

Asahi’s advertising campaigns emphasize social connections and health-conscious choices to connect with diverse consumers, reveals GlobalData

Asahi Group Holdings Ltd’s (Asahi) YouTube advertising campaigns of Q1 2025 (January – March 2025) focused on refreshment, social connections through endorsements, and health-conscious choices to engage diverse consumer segments. The campaigns showcase Asahi’s diverse portfolio, from the flagship Super Dry to non-alcoholic options, demonstrating the company’s commitment to meeting evolving consumer preferences. These approaches […]
Read more

Heineken’s campaigns unite tradition, sport, and social experience, reveals GlobalData

Heineken’s YouTube advertising campaigns during Q1 2025 (January to March) have illustrated a deliberate effort to integrate the brand into various facets of consumer life through targeted messaging and diverse thematic approaches. The “Pub Succession” campaign leverages cultural heritage and opportunity to engage a specific demographic. Football-focused campaigns like “The Social Screen” and “Excuses Bar” […]
Read more

Top 20 global biopharmaceutical companies witness 6% growth in market capitalization in Q1 2025, reveals GlobalData

The biopharmaceutical industry saw a strong start to 2025, despite ongoing uncertainty around the potential impact of Trump’s proposed pharmaceutical tariffs impacting global supply chains. Nevertheless, the industry remains resilient, with the top 20 biopharmaceutical companies reporting an upturn of 6% in aggregate market capitalization from $3.7 trillion as on 31 December 2024 to $3.9 […]
Read more

Davis Polk & Wardwell and Kirkland & Ellis top M&A legal advisers in retail sector during Q1 2025, reveals GlobalData

Davis Polk & Wardwell and Kirkland & Ellis were the top mergers and acquisitions (M&A) legal advisers in the retail sector during the first quarter (Q1) of 2025 by value and volume, respectively, according to the latest legal advisers league table by GlobalData, a leading data and analytics company. An analysis of GlobalData’s Deals Database […]
Read more
1 … 17 18 19 20 21 … 131